Cargando…

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis

INTRODUCTION: Vasculopathy, inflammatory fibrosis and functional autoantibodies (Abs) are major manifestations of systemic sclerosis (SSc). Abs directed against the angiotensin II type 1 receptor (AT(1)R) and endothelin-1 type A receptor (ET(A)R) are associated with characteristic disease features i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kill, Angela, Tabeling, Christoph, Undeutsch, Reinmar, Kühl, Anja A, Günther, Jeannine, Radic, Mislav, Becker, Mike O, Heidecke, Harald, Worm, Margitta, Witzenrath, Martin, Burmester, Gerd-Rüdiger, Dragun, Duska, Riemekasten, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978438/
https://www.ncbi.nlm.nih.gov/pubmed/24472528
http://dx.doi.org/10.1186/ar4457
_version_ 1782310564965384192
author Kill, Angela
Tabeling, Christoph
Undeutsch, Reinmar
Kühl, Anja A
Günther, Jeannine
Radic, Mislav
Becker, Mike O
Heidecke, Harald
Worm, Margitta
Witzenrath, Martin
Burmester, Gerd-Rüdiger
Dragun, Duska
Riemekasten, Gabriela
author_facet Kill, Angela
Tabeling, Christoph
Undeutsch, Reinmar
Kühl, Anja A
Günther, Jeannine
Radic, Mislav
Becker, Mike O
Heidecke, Harald
Worm, Margitta
Witzenrath, Martin
Burmester, Gerd-Rüdiger
Dragun, Duska
Riemekasten, Gabriela
author_sort Kill, Angela
collection PubMed
description INTRODUCTION: Vasculopathy, inflammatory fibrosis and functional autoantibodies (Abs) are major manifestations of systemic sclerosis (SSc). Abs directed against the angiotensin II type 1 receptor (AT(1)R) and endothelin-1 type A receptor (ET(A)R) are associated with characteristic disease features including vascular, inflammatory, and fibrotic complications indicating their role in SSc pathogenesis. Therefore, the impact of anti-AT(1)R and anti-ET(A)R Abs on initiation of inflammation and fibrosis was analyzed. METHODS: Anti-AT(1)R and anti-ET(A)R Ab-positive immunoglobulin G (IgG) from SSc patients (SSc-IgG) was used for experiments. Healthy donor IgG served as a normal control, and AT(1)R and ET(A)R activation was inhibited by antagonists. Protein expression was measured with ELISA, mRNA expression with real time-PCR, endothelial repair with a scratch assay, and collagen expression with immunocytochemistry. Transendothelial neutrophil migration was measured with a culture insert system, and neutrophil ROS activation with immunofluorescence. Neutrophils in bronchoalveolar lavage fluids (BALFs) were analyzed microscopically after passive transfer of SSc-IgG or NC-IgG into naïve C57BL/6J mice. KC plasma levels were quantified by a suspension array system. Histologic analyses were performed by using light microscopy. RESULTS: Anti-AT(1)R and anti-ET(A)R Ab-positive SSc-IgG induced activation of human microvascular endothelial cells (HMEC-1). Elevated protein and mRNA levels of the proinflammatory chemokine interleukin-8 (IL-8, CXCL8) and elevated mRNA levels of the vascular cell adhesion molecule-1 (VCAM-1) were induced in HMEC-1. Furthermore, activation of HMEC-1 with SSc-IgG increased neutrophil migration through an endothelial cell layer and activation of reactive oxygen species (ROS). SSc-IgG decreased HMEC-1 wound repair and induced type I collagen production in healthy donor skin fibroblasts. Effects of migration, wound repair, and collagen expression were dependent on the Ab-levels. Passive transfer of anti-AT(1)R and anti-ET(A)R Ab-positive SSc-IgG into naïve C57BL/6J mice increased neutrophil BALF counts. In parallel, increased levels of the murine functional IL-8 homologue, chemokine KC, were found in the plasma of SSc-IgG-treated mice as well as structural alterations of the lungs. CONCLUSIONS: We conclude that angiotensin and endothelin-receptor activation via anti-AT(1)R and anti-ET(A)R Abs mediate pathogenic effects, indicating their contribution to pathogenesis of SSc. Therefore, anti-AT(1)R and anti-ET(A)R Abs could provide novel targets for therapeutic intervention in the treatment of SSc.
format Online
Article
Text
id pubmed-3978438
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39784382014-04-09 Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis Kill, Angela Tabeling, Christoph Undeutsch, Reinmar Kühl, Anja A Günther, Jeannine Radic, Mislav Becker, Mike O Heidecke, Harald Worm, Margitta Witzenrath, Martin Burmester, Gerd-Rüdiger Dragun, Duska Riemekasten, Gabriela Arthritis Res Ther Research Article INTRODUCTION: Vasculopathy, inflammatory fibrosis and functional autoantibodies (Abs) are major manifestations of systemic sclerosis (SSc). Abs directed against the angiotensin II type 1 receptor (AT(1)R) and endothelin-1 type A receptor (ET(A)R) are associated with characteristic disease features including vascular, inflammatory, and fibrotic complications indicating their role in SSc pathogenesis. Therefore, the impact of anti-AT(1)R and anti-ET(A)R Abs on initiation of inflammation and fibrosis was analyzed. METHODS: Anti-AT(1)R and anti-ET(A)R Ab-positive immunoglobulin G (IgG) from SSc patients (SSc-IgG) was used for experiments. Healthy donor IgG served as a normal control, and AT(1)R and ET(A)R activation was inhibited by antagonists. Protein expression was measured with ELISA, mRNA expression with real time-PCR, endothelial repair with a scratch assay, and collagen expression with immunocytochemistry. Transendothelial neutrophil migration was measured with a culture insert system, and neutrophil ROS activation with immunofluorescence. Neutrophils in bronchoalveolar lavage fluids (BALFs) were analyzed microscopically after passive transfer of SSc-IgG or NC-IgG into naïve C57BL/6J mice. KC plasma levels were quantified by a suspension array system. Histologic analyses were performed by using light microscopy. RESULTS: Anti-AT(1)R and anti-ET(A)R Ab-positive SSc-IgG induced activation of human microvascular endothelial cells (HMEC-1). Elevated protein and mRNA levels of the proinflammatory chemokine interleukin-8 (IL-8, CXCL8) and elevated mRNA levels of the vascular cell adhesion molecule-1 (VCAM-1) were induced in HMEC-1. Furthermore, activation of HMEC-1 with SSc-IgG increased neutrophil migration through an endothelial cell layer and activation of reactive oxygen species (ROS). SSc-IgG decreased HMEC-1 wound repair and induced type I collagen production in healthy donor skin fibroblasts. Effects of migration, wound repair, and collagen expression were dependent on the Ab-levels. Passive transfer of anti-AT(1)R and anti-ET(A)R Ab-positive SSc-IgG into naïve C57BL/6J mice increased neutrophil BALF counts. In parallel, increased levels of the murine functional IL-8 homologue, chemokine KC, were found in the plasma of SSc-IgG-treated mice as well as structural alterations of the lungs. CONCLUSIONS: We conclude that angiotensin and endothelin-receptor activation via anti-AT(1)R and anti-ET(A)R Abs mediate pathogenic effects, indicating their contribution to pathogenesis of SSc. Therefore, anti-AT(1)R and anti-ET(A)R Abs could provide novel targets for therapeutic intervention in the treatment of SSc. BioMed Central 2014 2014-01-28 /pmc/articles/PMC3978438/ /pubmed/24472528 http://dx.doi.org/10.1186/ar4457 Text en Copyright © 2014 Kill et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kill, Angela
Tabeling, Christoph
Undeutsch, Reinmar
Kühl, Anja A
Günther, Jeannine
Radic, Mislav
Becker, Mike O
Heidecke, Harald
Worm, Margitta
Witzenrath, Martin
Burmester, Gerd-Rüdiger
Dragun, Duska
Riemekasten, Gabriela
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
title Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
title_full Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
title_fullStr Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
title_full_unstemmed Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
title_short Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
title_sort autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978438/
https://www.ncbi.nlm.nih.gov/pubmed/24472528
http://dx.doi.org/10.1186/ar4457
work_keys_str_mv AT killangela autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT tabelingchristoph autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT undeutschreinmar autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT kuhlanjaa autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT guntherjeannine autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT radicmislav autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT beckermikeo autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT heideckeharald autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT wormmargitta autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT witzenrathmartin autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT burmestergerdrudiger autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT dragunduska autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis
AT riemekastengabriela autoantibodiestoangiotensinandendothelinreceptorsinsystemicsclerosisinducecellularandsystemiceventsassociatedwithdiseasepathogenesis